Heather Khassian

Heather Khassian

Bracewell & Giuliani LLP

Contact  |  View Bio  |  RSS

Latest Publications

Share:

Re-Calculating Patent Term Adjustments Once Again

The Federal Circuit has adjusted the way we calculate Patent Term Adjustments (PTA) once again with its holdings in Novartis and Exelixis. The Federal Circuit held that the United States Patent and Trademark Office (USPTO)...more

1/27/2014 - Exelixis Novartis Patent Term Adjustment Patent Terms Patents USPTO

Supreme Court - Being Unanimous Appears to be Part of the Justices' DNA

On June 13, 2013, the U.S. Supreme Court unanimously decided in Association for Molecular Pathology v. Myriad Genetics, Inc. that naturally occurring DNA segments are not patent eligible because they are products of nature...more

6/17/2013 - AMP v Myriad DNA Human Genes Myriad Patent-Eligible Subject Matter Patents SCOTUS

Batting Practice with DNA Patents at the U.S. Supreme Court

The Supreme Court heard oral arguments today in Association of Molecular Pathology vs. Myriad Genetics (Docket 12-398) regarding the patent eligibility of isolated DNA sequences. More specifically, they probed both parties in...more

4/17/2013 - AMP v Myriad DNA Gene Patenting Human Genes Oral Argument Patent-Eligible Subject Matter Patents Recombinant DNA SCOTUS

3 Results
|
View per page
Page: of 1